Michael Schmertzler

Coltec Industries, Inc. manufactures aerospace and defense products. The firm provides landing gear systems and aircraft flight controls, turbine components and compressor rotating parts primarily for aircraft gas turbine engines. It also offers seals, gaskets material, and truck products; marketing parts for fairbanks morse diesel engines and accessories. The company was founded in 1911 and is headquartered in Charlotte, NC.

A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues.

Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA.

Credit Suisse First Boston LLC provides global investment banking services in the United States. It provides private banking and financial advisory services and banking products. Its businesses include securities underwriting, sales & trading, investment banking, private equity, alternative assets, financial advisory services, investment research and asset management. It is headquartered in New York, NY.

Segway, Inc. develops, manufactures, distributes, and markets self-balancing and zero-emissions light electric transportation devices. It also provides zero-emissions personal transporters for indoor, sidewalk, cross-terrain, and patrol use, and PT accessories, such as cargo, lighting, parking, infokey, mats, travel, batteries, and apparel and collectibles. The company was founded by Dean L. Kamen in 1999 and is headquartered in Bedford, NH.

Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT.